CompletedPhase 1NCT03197623
Safety and Tolerability of Intravenous LLP2A-Alendronate for Osteopenia Secondary to Glucocorticoids
Studying Osteonecrosis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Nancy E. Lane, MD
- Principal Investigator
- Nancy E Lane, MDUC Davis Health
- Intervention
- LLP2A-ALENDRONATE(drug)
- Enrollment
- 58 target
- Eligibility
- 20-85 years · All sexes
- Timeline
- 2016 – 2021
Study locations (4)
- West Coast Clinical Trials (WCCT), Cypress, California, United States
- Diablo Clinical Research, Walnut Creek, California, United States
- Altoona Center for Clinical Research, Duncansville, Pennsylvania, United States
- Metroplex Clinical Research Center, Dallas, Texas, United States
Collaborators
California Institute for Regenerative Medicine (CIRM)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT03197623 on ClinicalTrials.govOther trials for Osteonecrosis
Additional recruiting or active studies for the same condition.
- ENROLLING BY INVITATIONNANCT07177378Management of Medication Related Osteonecrosis of the Jaws With Double Periosteal Flap ClosureTanta University
- RECRUITINGNCT06420284Immunological Parameters Between MRONJ StagesMarmara University
- RECRUITINGNCT06430762Therapeutic Exposures and Risk Factors in MRONJMarmara University
- RECRUITINGNANCT06129214Partial Synovectomy in Articular Side of Quadriceps Tendon Verified to Reduce Crepitus in Retrospective StudyGangnam Severance Hospital
- RECRUITINGPHASE2NCT05664815Human Amniotic Membrane (hAM) for Stage II Maxillomandibular Osteonecrosis ManagementCentre Hospitalier Universitaire de Besancon
- RECRUITINGNCT04098146Registry to Collect Data on Patients Undergoing Segmental Mandibular Defect Reconstruction Following Oral Squamous Cell Carcinoma Resection and Drugs-induced OsteonecrosisAO Innovation Translation Center
- RECRUITINGNCT06457776Medication Related Osteonecrosis of the Jaws (MRONJ) in a Cohort of Patients Treated by Antiresorptive DrugsCatholic University of the Sacred Heart
- ENROLLING BY INVITATIONNCT05329558Local and Systemic Changes in Osteonecrosis of the JawboneMedical University of Graz